BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Biotech Bay

  Veeva CDB Application to Streamline Aggregation, Cleaning, and Transformation of Clinical Data

  Veeva Systems (NYSE: VEEV) today announced the availability of Veeva CDB, a first-of-its-kind solution for aggregating, cleaning, and transforming clinical data.

  October 18, 2022

   · 

  4 min read
• Biotech Bay

  Veeva Introduces New ePRO Application for Faster Access to Patient Data

  Veeva Systems (NYSE: VEEV) today announced the availability of Veeva ePRO , a key advancement in patient-centric digital trials.

  October 18, 2022

   · 

  3 min read
• Biotech Beach

  WELL Health Announces Rebranding, Changes Name to Artera

  Well Health Inc. , a SaaS digital health leader in patient communications and the 2021 and 2022 Best in KLAS winner in Patient Outreach, today announces it has rebranded to Artera.

  October 18, 2022

   · 

  3 min read
• Deals

  BioIntelliSense Acquires AlertWatch® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions

  BioIntelliSense Acquires AlertWatch ® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions.

  October 18, 2022

   · 

  4 min read
• Genetown

  Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway

  Ikena Oncology, Inc. today provided a research & development update on the Company’s lead targeted oncology program in TEAD inhibition.

  October 18, 2022

   · 

  7 min read
• Drug Development

  Alphyn Biologics Announces Enrollment Passes Halfway Point in Phase2a Clinical Trial of Mild-to-Moderate Atopic Dermatitis Treatment

  Alphyn Biologics announced today that enrollment in its Phase2a clinical trial of AB-101a for mild-to-moderate atopic dermatitis (AD) has passed the halfway point.

  October 18, 2022

   · 

  3 min read
• BioMidwest

  UPDATE -- Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System

  Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery as the standard of care in spine, announced the rapid global expansion and international use of its FlareHawk® Interbody Fusion System.

  October 18, 2022

   · 

  4 min read
• Biotech Bay

  Kyverna Therapeutics Submits IND for Novel CAR T-Cell Therapy to Treat Lupus Nephritis

  Kyverna Therapeutics today announced the filing of its first Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for KYV-101, a novel therapy for the treatment of lupus nephritis.

  October 18, 2022

   · 

  4 min read
• Business

  Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

  Aptinyx Inc. today announced that the company will host a conference call and live webcast on Tuesday, November 8, 2022 at 5:00 p.m. ET to report third quarter 2022 financial results and discuss recent business highlights.

  October 18, 2022

   · 

  1 min read
• Business

  Vitrolife AB: Conference call interim report - October 18, 2022

  Invitation to attend Vitrolife AB conference call regarding presentation of the interim report January - September 2022.

  October 18, 2022

   · 

  1 min read